A detailed history of Capital Fund Management S.A. transactions in Cytokinetics Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 40,446 shares of CYTK stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,446
Previous 35,522 13.86%
Holding current value
$1.87 Million
Previous $1.88 Million 1.44%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$46.36 - $58.62 $228,276 - $288,644
4,924 Added 13.86%
40,446 $1.9 Million
Q3 2024

Nov 13, 2024

SELL
$51.22 - $60.16 $1.39 Million - $1.63 Million
-27,160 Reduced 43.33%
35,522 $1.88 Million
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $2.25 Million - $3.53 Million
47,079 Added 301.73%
62,682 $3.4 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $994,691 - $1.69 Million
15,603 New
15,603 $1.09 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.35B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.